What, a coronavirus vaccine? It’s has been made official, this pandemic may finally be reaching its end! Pfizer and BioNTech recently announced that their trials on the new vaccine showed 95% efficacy. As winter approaches, this vaccine is more needed than ever. In fact, several countries such as France and Germany, are showing worse results during this second wave of COVID-19.
Moreover, many people took their complaints to social media, questioning the viability and safety of this vaccine. The most common question has been: “Would you do it?” For that reason, we prepared this post to simplify the findings, and tell the truth about the new coronavirus vaccine.
8 Months Trials And Thousands Of Participants
The study/trials results showed a historic 95% efficacy, which marks a new milestone for health reaserch. In addition, these results weren’t obtained through a small sample of people, but rather 43,661 participants of 18 years old and above, to be exact. The mRNA-based COVID-19 vaccine showed consistency across all ages and demographics.
The success of the trials revolved around achieving protection against coronavirus, starting from the first dose of 30 mg.
Is The Vaccine Secure?
Now, to the big question. Many people are concerned with the safety of this vaccine. However, it’s easy to make false assumptions when you are not well-informed, and do not know how vaccines work. According to proven scientific work, vaccines are formed to give the body an antibody against an unknown virus. In fact, developed vaccines over the years have proved effective, and saved many lives. For example, in the early 1900, polio disease killed many in Africa, and it wasn’t until the vaccine was provided that people became safe.
In conclusion, vaccines are secure, and do more good than harm. Luckily, even those believing in conspiracy theories and won’t approve of the vaccine can still be protected from coronavirus, if a large part of the community is vaccinated.
When Will It Be Available?
According to the latest statement provided by Pfizer and BioNTech, ”the companies expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021.” In addition, over 170 countries are aiming to provide their people with the vaccine by early 2021. It is obvious that it’s not going to be an easy task manufacturing enough doses for everyone, but it is expected that the first target of the vaccine will be elderly and people with underlying health conditions. (aka the most vulnerable groups to COVID-19.)
Photos: Freepik, WHO.